NCT04270617 The Effect of Yoga Practice on Chronic Back Pain
| NCT ID | NCT04270617 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Chronic Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2019-12-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2019-12-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic low back pain is notoriously difficult to treat and is a primary contributor to lost work days and excessive health expenditures, and whose treatment has, in part, contributed to the opioid crisis. Surgery is only an option in a minority of these patients, usually confined to those with structural instability. Yoga is an ancient modality whose benefits are currently being studied.
Eligibility Criteria
Inclusion Criteria: * Willingness to and ability to participate in study procedures * Chronic back pain (pain above the gluteal cleft of at least 3 months duration) Exclusion Criteria: * Indication for surgery (i.e., fracture, infection, scoliosis, spondylolisthesis) * Cardiac, pulmonary or other medical comorbidities that preclude participation in yoga practice
Contact & Investigator
Erich Anderer
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT04270617 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04270617 currently recruiting?
Yes, NCT04270617 is actively recruiting participants. Contact the research team at erich.anderer@nyulangone.org for enrollment information.
Where is the NCT04270617 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04270617 clinical trial?
NCT04270617 is sponsored by NYU Langone Health. The principal investigator is Erich Anderer at NYU Langone Health. The trial plans to enroll 200 participants.